Health and population

Health and population dynamics are intertwined, embodying an intricate relationship with significant implications on the Sustainable Development Goals (SDGs). Health is fundamentally at the center of these 17 global goals, aimed to transform the world by 2030. Specifically, Goal 3 endeavors to "Ensure healthy lives and promote well-being for all at all ages." It acknowledges that health is pivotal to human life quality, social cohesion, and sustainable development. Inextricably linked to this are the complexities of population dynamics, including growth rates, age structure, fertility and mortality rates, and migration patterns.

With the world's population projected to exceed 9.7 billion by 2050, the pressure on health systems will undoubtedly escalate. The demographic transition, with an aging population and an increasing prevalence of non-communicable diseases, poses new challenges for health systems globally. Additionally, areas with high fertility rates often overlap with extreme poverty, resulting in heightened health risks, including higher maternal and child mortality rates, malnutrition, and infectious diseases.

Moreover, rapid urbanization and migration present both opportunities and threats to health. While urban areas may provide better access to healthcare, they also harbor risks of disease transmission, air and water pollution, and social determinants of health like inadequate housing and social inequality. Simultaneously, migrants often face disproportionate health risks due to unstable living conditions, exploitation, and limited access to healthcare services.

Achieving the SDGs will necessitate comprehensive approaches that consider the intricate interplay of health and population dynamics. It means strengthening health systems, promoting universal health coverage, and addressing social determinants of health. It also implies crafting policies that recognize demographic realities and foster an environment conducive to sustainable development. Only by understanding and harnessing these dynamics can the world meaningfully progress towards realizing the SDGs, ensuring healthy lives and well-being for all.

Elsevier, Alzheimer's Disease and Advanced Drug Delivery Strategies, Volume , 1 January 2023
Alzheimer's disease (AD) is a severe global public health issue because it is an irreversible neurodegeneration of the brain that impairs personality, cognition, memory, and other functions before it ultimately results in death from total brain failure.
Elsevier, Side Effects of Drugs Annual, Volume 45, January 2023
Medications used in the treatment of Alzheimer's disease include the acetylcholinesterase inhibitors (AChEIs, i.e., donepezil, rivastigmine, and galantamine), the N-methyl-D-aspartate receptor (NDMAR) antagonist, memantine, and the anti-amyloid beta monoclonal antibody, aducanumab.
Elsevier, Diet and Nutrition in Neurological Disorders, Volume , 1 January 2023
This chapter discusses any plausible correlation between malnutrition and the onset of Alzheimer's disease. An overview of Alzheimer's pathophysiology is included to offer an understanding of the various underlying causes leading to its manifestation.
Diagram of Esophageal Atresia & Tracheoesophageal Fistula
This article ties to SDG 3. This resource, created together by Osmosis and the National Organization for Rare Diseases (NORD), aims to increase the knowledge and awareness about the rare birth defect Esophageal Atresia & Tracheoesophageal Fistula. This disease occurs when the esophagus fails to develop correctly, essentially ending in a blind pouch that is commonly connected to the trachea, creating a tracheoesophageal fistula.
Elsevier,

The Youth Athlete: A Practitioner's Guide to Providing Comprehensive Sports Medicine Care, Volume , 1 January 2023

This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by providing a comprehensive review of specific considerations for the promotion of sports participation in youth athletes with intellectual disabilities.
Elsevier,

Handbook of Lifespan Cognitive Behavioral Therapy: Childhood, Adolescence, Pregnancy, Adulthood, and Aging, Volume , 1 January 2023

This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by discussing the application of cognitive behavior therapy, an evidence-based psychological approach in adolescents suffering from Asperger syndrome with comorbid depressive disorder.
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by presenting ASD as a complex, multisystem neurodevelopmental condition with origins in prenatal life.
Elsevier,

Handbook of Clinical Neurology, Volume 196, January 2023

This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by promoting plasticity-guided concepts, enhanced by neurophysiological and neuroimaging approaches to address the preservation of motor function in people with multiple sclerosis.
Elsevier,

The Youth Athlete: A Practitioner's Guide to Providing Comprehensive Sports Medicine Care, Volume , 1 January 2023

This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by treating access and inclusion as human rights issue and highlighting information to providers about caring for athletes with physical disabilities.
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by reviewing the current therapies for neurological disorders and their limitations.

Pages